Singapore, March 13 -- On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke with Pengfei Chen, Vice President, Healthcare at the Singapore Economic Development Board (EDB). As global pharmaceutical companies continue to expand their manufacturing footprint in Asia Pacific, Singapore has emerged as a trusted destination for advanced biopharmaceutical production. In this conversation, Chen discusses how Singapore's strong regulatory framework, integrated industry ecosystem, talent development programmes, and investments in artificial intelligence and digital manufacturing are strengthening its role as a strategic hub for global biomanufacturing.

Singapore offe...